A chemotherapeutic vitamin D analogue, EB1089, kills tumor cells via a caspase-independent pathway that results in chromatin condensation and DNA fragmentation. Employing transmission-and immunoelectronmicroscopy as well as detection of autophagosome-associated LC3-b protein in the vacuolar structures, we show here that EB1089 also induces massive autophagy in MCF-7 cells. Interestingly, inhibition of autophagy effectively hindered apoptosis-like nuclear changes and cell death in response to EB1089. Furthermore, restoration of normal levels of beclin 1, an autophagyinducing tumor suppressor gene that is monoallelically deleted in MCF-7 cells, greatly enhanced the EB1089-induced nuclear changes and cell death. Thus, EB1089 triggers nuclear apoptosis via a pathway involving Beclin 1-dependent autophagy. Surprisingly, tumor cells depleted for Beclin 1 failed to proliferate suggesting that even though the monoallelic depletion of beclin 1 in human cancer cells suppresses EB1089-induced autophagic death, one intact beclin 1 allele is essential for tumor cell proliferation.
Introduction
Caspase-mediated apoptosis is the best-defined cell death program counteracting tumor growth. With respect to the ability of some cells to escape apoptosis, it would, however, be dangerous for the organism to depend on a single executer program for the clearance of unwanted and potentially harmful cells. Indeed, evidence for alternative death pathways where lysosomes and cathepsins function as executioners is emerging. [1] [2] [3] The lysosomal membrane permeabilization followed by the release of cathepsins and other lysosomal hydrolases to the cytosol is the key event in the lysosomal death pathway. Once released to the cytosol, cathepsins, especially cysteine cathepsins B and L and aspartyl cathepsin D, may trigger the mitochondrial outer membrane permeabilization followed by caspase-mediated apoptosis, 4, 5 or mediate caspase-independent programmed cell death (PCD). 6, 7 Notably, both immortalization and transformation sensitize cells to the lysosomal death pathway, 8 and lysosomal membrane permeabilization can be triggered by many cancer relevant stimuli such as death receptors of tumor necrosis factor (TNF) receptor family, p53 tumor suppressor protein, DNA-damaging agents, microtubule disrupting agents and oxidative stress. 2 Lysosomes are also involved in macroautophagy (hereafter referred to as autophagy), a process recently found to be deregulated in tumors. 2, 9 Autophagy is characterized by an increase in the number of autophagosomes, vacuoles surrounded by a double membrane, that sequester cytoplasm or organelles. Subsequently, autophagosomes fuse with lysosomes to form autolysosomes, where sequestered material is digested. During physiological conditions, constitutive autophagy plays an important role in normal protein and organelle turnover. Furthermore, autophagy can be enhanced by several cancer-related stimuli, for example, oncogenic Ras, 10 starvation, 11 endostatin, 12 radiation, 13 anti-estrogens, 14 several other putative anticancer agents 15, 16 as well as cytokines such as TNF 17 and interferon gamma. 11 An essential role for autophagy in the control of cancer progression is supported by recent data showing that beclin 1, an autophagy gene that is monoallelically deleted in up to 40-75% of sporadic breast, ovarian and prostate cancer, acts as an effective haploinsufficient tumor suppressor in mice. 18, 19 The mechanism whereby autophagy provides the barrier to tumorigenesis is still speculative. Autophagy can lead to growth arrest and reduction in cell number and several death forms are associated with appearance of autophagic vesicles. 20 However, only very few data directly connect autophagy to cell death, 14, 21, 22 and the putative signaling from autophagy to cell death is completely unknown. One possibility is that a certain amount of functional mitochondria is required for energy production and thereby for cell survival. A massive induction of autophagy could therefore lead to starvation as the cell 'cannibalizes' itself. Alternatively, lysosomal or autolysosomal membrane permeabilization could result in the release of cathepsins into the cytosol and cathepsin-dependent death execution. Whereas the role of cytosolic cathepsins in autophagy remains to be studied, autophagic degeneration clearly does not depend on caspase activation. 10, 23 Instead, autophagy can be blocked by pharmacological inhibition of class III phosphatidylinositol 3-kinase, 24 or genetic depletion of other proteins involved in the autophagosome formation, for example, Beclin 1 and Atg7. 22 It should be noted that autophagy can serve as a protective mechanism against starvation and apoptosis by recycling macromolecules and removing damaged mitochondria and other organelles, respectively. 16, [25] [26] [27] EB1089, a vitamin D3 analog developed for the treatment of cancer, induces growth arrest, differentiation and cell death in malignant cells of various origins. 28 In MCF-7 breast cancer cells, it triggers caspase-independent apoptosis-like PCD that is associated with an increase in intracellular free calcium [Ca 2 þ ] i , activation of calpain (a cytosolic calcium-regulated cysteine protease) and increased expression of cysteine cathepsins. [29] [30] [31] Despite the lack of detectable caspase activation, the dying cells present several characteristics of apoptosis, that is, rounding, shrinkage and detachment of cells as well as DNA strand breaks and fragmentation.
Our earlier observations showing that EB1089-treated MCF-7 cells display a dramatic increase in intracellular vacuoles and cysteine cathepsin expression prompted us to study the possible role of lysosomes and autophagy in EB1089-induced PCD. To this end, we compared EB1089-induced lysosomal changes to those induced by TNF and thapsigargin (TG; an irreversible inhibitor of Serca, an endoplasmatic reticulum calcium ATPase). TNF was chosen as a 'control' treatment because it can in addition to the wellcharacterized caspase-dependent apoptosis pathway induce lysosomal membrane permeabilization 6 and/or autophagy, 17 and TG, because it akin to EB1089 triggers both early and delayed increase in [Ca 2 þ ] i . 32 We find that cell death induced by EB1089 is associated with autophagy, and that monoallelic deletion of beclin 1 confers partial resistance to EB1089. We also show that tumor cell growth is severely compromised upon knockdown of Beclin 1, suggesting a dual role for Beclin 1 in cancer progression.
Results

EB1089, TNF and TG trigger early changes in volume and integrity of the acidic compartment
To assess the effect of EB1089, TNF and TG on the lysosomal compartment, we investigated the volume of the acidic compartment (VAC) by staining MCF-7 breast cancer cells with lysotracker-red, a basic cell-permeable probe that accumulates in acidic vesicles. Confocal microscopy revealed a dramatic increase in the size and number of acidic vesicles in response to EB1089 (100 nM for 5 days) and TNF (10 ng/ml for 24 h), whereas TG-treated (10 nM for 48 h) cells had almost completely lost their ability to accumulate lysotrackerred ( Figure 1a) . In EB1089-treated cells, the increase in VAC was associated with an increase in total cysteine cathepsin activity reflecting enhanced lysosomal activity (Figure 1a and  b) . Similarily, TG-induced decrease in lysotracker-red staining was associated with decreased total cysteine cathepsin activity, whereas cells treated with TNF for 24 h had slightly decreased lysosomal protease activity in spite of increased VAC (Figure 1a and b) . This could reflect the ability of TNF 6 and possibly also TG to induce lysosomal membrane permeabilization. Indeed, TNF-treated MCF-7 cells displayed lysosomal membrane permeabilization that started 12-15 h after the addition of TNF, and the TG-induced loss of VAC was associated with a time-dependent destabilization of lysosomes resulting in a complete release of cysteine cathepsin activity from the lysosomes into the cytosol (Figure 1c and data not shown). Contrary to TNF and TG, EB1089 did not change the ratio between cytosolic and total cysteine cathepsin activities (Figure 1c ). It should, however, be noted that the absolute cytosolic cysteine cathepsin activity increased also in EB1089-treated cells due to an over 2.5-fold increase in the total activity (Figure 1b) . EB1089-induced increase in VAC (not shown) and lysosomal protease activity were time-dependent starting before any apparent changes in cell morphology (not shown) or DNA fragmentation were detectable, that is, by one day of the treatment ( Figure 1b 
EB1089 and TNF increase the uptake of monodansylcadaverine in MCF-7 cells
Next, we examined whether the changes in VAC observed in EB1089-, TNF-and TG-treated cells were associated with altered autophagy. For this purpose we stained the drugtreated cells with monodansylcadaverine (MDC), an autofluorescent base that has been reported to accumulate in autophagic vacuoles, 33 and analyzed them by fluorescence microscopy. MCF-7 cells displayed only very few weakly staining granules, whereas approximately 40% of EB1089-and 30% of TNF-treated cells accumulated MDC into granular structures of high fluorescence intensity (Figure 2a and b) . TG-treated cells showed an increase in diffuse cytosolic staining, but a complete lack of the granular staining ( Figure  2a and b) . The TNF-induced granular staining and the TGinduced increase in the cytosolic MDC staining observed in microscopic analysis were quantified by spectrofluorometer analysis of live cells that revealed approximately 1.8-and 2.1-fold increase in fluorescence intensity, respectively (Figure 2c) . In order to test whether MDC-positive vacuoles were of autophagic origin, we added 10 mM 3-methyladenine (3-MA), an inhibitor of class III phosphatidylinositol 3-kinase and autophagosome formation, 34 to the cells 2 days before the analysis. Surprisingly, 3-MA treatment alone increased both the number of MDC-positive cells and especially the intensity of the staining (Figure 2b and c) . It also failed to significantly inhibit the EB1089-and TNF-induced increase in the number of MDC-positive cells questioning the specificity of the probe (Figure 2b) . Indeed, costaining of EB1089-and TNF-treated MCF-7 cells with MDC and lysotracker-red revealed nearly complete colocalization of the probes, suggesting that they accumulate in same organelles, presumably lysosomes (Figure 2d ). Accordingly, MDC failed to differentiate between lysosomes and autophagic vesicles also in MCF-7 cells treated with known inducers of autophagy, that is, tamoxifen and rapamycin (Figure 2d) . 14, 35 It should also be noted that all the MDC stainings presented above were performed in live cells. Fixation of the cells with 3.7% formaldehyde almost completely abrogated the granular staining even in cells known to accumulate autophagosomes (data not shown).
EB1089 induces autophagy in MCF-7 cells
To detect the formation of autophagic vesicles in a more reliable manner, we expressed a fusion protein consisting of DsRed1 and microtubule-associated protein 1 light chain 3-b (LC3-b), a human ortholog of a yeast autophagy protein Atg8, 36 together with histone-2 beta-enhanced green fluorescence protein fusion protein (H2B-eGFP) in MCF-7 cells. To verify that DsRed1-LC3-b translocated to autophagic vesicles as reported earlier, 36 we treated the transfected cells with tamoxifen or rapamycin. Whereas control cells displayed a very weak diffuse staining with a few red granules, large proposition of the cells treated with either drug displayed strong red granular staining as analyzed by confocal microscopy (Figure 3a and b) . To further validate the assay, we cotransfected DsRed1-LC3-b with GFP-tagged rat LC3-b that has been shown to localize to autophagic membranes. 37 The proteins showed nearly complete colocalization both in untreated (weak diffuse staining) and autophagic (punctuate) cells (data not shown). Therefore, we concluded that To further elucidate the origin of the vacuoles and other morphological changes induced by EB1089, TNF and TG, we examined the morphology of the dying MCF-7 cells by transmission electron microscopy (EM) ( Figure 4 ). As we have shown previously, 5-day treatment with EB1089 induced an apoptosis-like nuclear morphology characterized by a partially condensed chromatin marginalized along the nuclear and h). All three stimuli increased the number of electron light vesicles. Almost all TG-induced vesicles were surrounded by ribosomes and were therefore likely to originate from rough endoplasmatic reticulum (ER) (Figure 4h ). Also, EB1089-treated cells had some ribosome-containing vesicles (data not shown) in agreement with earlier data showing that both TG and EB1089 induce ER stress. 31, 38 Additionally, cells treated with EB1089 and TNF had an extraordinary induction of ribosome-free vesicles consistent with the massive VAC increase triggered by both drugs (Figure 4c-g ). Contrary to either normal or slightly condensed mitochondria in cells treated with TNF or TG (Figure 4g and h), dramatic mitochondrial changes characterized by breakage and removal of the cristae were apparent in cells treated with EB1089 (Figure 4c-f) . Damaged mitochondria were found already 2 days after the treatment (Figure 4c ), and they were also frequent in cells without chromatin condensation ( 
EB1089-induced cell death is inhibited by 3-MA
To investigate the role of autophagic activity in EB1089-induced death signaling, we treated MCF-7 cells with 10 mM 3-MA for the last 2 days of the 5-day treatment with EB1089. 3-MA not only inhibited the EB1089-induced appearance of damaged mitochondria and autophagic vesicles but also the condensation of chromatin as analyzed by EM (Figures 4f, 6a and b). Furthermore, 3-MA inhibited EB1089-induced rounding and detachment of the cells as analyzed by phase contrast microscopy (data not shown), DNA fragmentation (Figure 6c ) as well as permeabilization of the plasma membrane (Figure 7e ). In accordance with the lack of autophagic markers in TNF-and TG-treated cells, 3-MA failed to inhibit morphological changes, rupture of the outer membrane and DNA fragmentation induced by these stimuli ( Figure 6C and data not shown).
An autophagy-associated tumor suppressor gene beclin 1 is monoallelically deleted in MCF-7 cells. 40, 41 To test whether this deletion confers resistance to EB1089-mediated autophagic cell death demonstrated above, we increased the expression level of Beclin 1 by ectopic expression. We established several Beclin 1-expressing single cell clones and selected two clones with approximately a doubling in the 
Beclin 1 is required for the proliferation of cancer cells
In order to test whether EB1089-induced autophagic PCD was dependent on Beclin 1, we depleted MCF-7 cells for Beclin 1 by two independent and nonoverlapping small interfering RNAs (siRNA) (Figure 8a and data not shown).
We were, however, unable to assess this question, because the Beclin 1-depleted MCF-7 cells ceased to grow and displayed stressed morphology with numerous long filopodia (Figure 8b ). This phenotype was evident already 2 days after 
Discussion
Since the identification of Beclin 1 as a tumor suppressor protein that mediates autophagy and thereby slows down the growth of tumor cells, 40 there have been several reports providing evidence for autophagy-mediated negative control of tumorigenesis.
2,9 PTEN, Bin1 and death-associated protein kinase are among the autophagy-promoting proteins that akin to Beclin 1 display tumor suppressive properties. Furthermore, tumor cells originating from cancer types that rarely carry activating mutations in the ras proto-oncogene (e.g. glioblastomas and gastric carcinomas) show increased autophagy and decreased survival upon ectopic expression of activated Ras. 10 Finally, high incidence of spontaneous tumors in mice with monoallelic disruption of Beclin 1 has provided strong genetic evidence for autophagy-mediated suppression of tumorigenesis. 18, 19 In this report, we identify two opposing roles for Beclin 1 in the control of tumor cell growth, that is, sensitization to autophagy and requirement for cell proliferation. Restoration of normal Beclin 1 levels in MCF-7 breast cancer cells that have monoallelic deletion of beclin 1 gene greatly sensitized them to autophagy. Whereas the antiproliferative effect of Beclin 1 in starved MCF-7 cells is due to autophagy-mediated inhibition of cell proliferation, 40 our data show that Beclin 1 expression dramatically increased EB1089-induced autophagy-dependent cell death. Both the kinetics and the extent of EB1089-induced death were greatly accelerated in cells expressing ectopic Beclin 1. The downregulation of autophagic activity in malignant cells may thus promote tumor growth both by increasing the growth rate and by allowing the tumor cells to escape autophagic cell death. If autophagy was a purely antitumorigenic mechanism, its inhibition should enhance tumor cell proliferation and survival. However, the knock down of the remaining Beclin 1 expression in MCF-7 cells almost completely inhibited cell proliferation in normal culture conditions. Similar growth inhibition was observed in HeLa cervix carcinoma cells suggesting that some Beclin 1 is necessary for tumor cell growth. This hypothesis is supported by earlier data showing that contrary to most known tumor suppressor genes that commonly show loss of heterogeneity, the wild-type beclin 1 allele has never been found mutated nor silenced in tumors occurring in beclin 1 heterozygous mice or human breast carcinoma cell lines. 18, 19, 41 It remains to be studied whether the requirement for Beclin 1 in cell proliferation is specific for cancer cells. Beclin 1 is, however, not required for the proliferation of embryonic stem cells under standard culture condition or for the early growth of embryonic tissues.
19 Beclin 1-deficient embryos are, however, smaller than wild-type embryos and they die around embryonic day 8, because of their inability to undergo remodeling and proper differentiation of ventral endoderm. 19 It should also be noted that it is as yet unclear whether the dependence of tumor cells on Beclin 1 is due to its essential role in autophagy or whether it mediates an autophagy-independent survival or growth function in tumor cells. The former is supported by data showing that autophagy can suppress latent and stressinduced apoptotic programs. 11, 16, 25, 26 The autophagymediated cytoprotective effect could be brought about by recycling of nutrients and/or removal of damaged organelles including mitochondria that would otherwise release cytochrome c or oxidative radicals and initiate caspase activation or oxidative stress response, respectively.
Contrary to earlier reports suggesting that TNF induces autophagy, 11, 17 TNF-induced increase in VAC and MDC staining in MCF-7 cells reflected increased lysosomal volume rather than autophagy. TNF failed to trigger autophagosome formation as analyzed by the translocation of DsRed1-LC3-b into the vacuolar structures and by EM. Furthermore, the regulation of autophagic activity by 3-MA and Beclin 1 expression failed to affect the survival of TNF-treated cells. Similarly, TG-induced cell death was unaffected by altering autophagic activity. Instead, TG induced a massive lysosomal membrane permeabilization that was reflected by almost complete disappearance of all acidic vacuoles and a release of all lysosomal cathepsins into the cytosol. It has been suggested that a partial lysosomal leakage would result in apoptosis-like PCD, whereas the massive leakage would lead to the disruption of the plasma membrane and necrotic death. 42 TG-treated cells showed, however, mainly apoptosis-like changes like nuclear and chromatin condensation as well as DNA fragmentation rather than necrosis-associated mitochondrial swelling or massive plasma membrane lysis.
MDC has been reported to specifically label autophagic vesicles, 33 and it has been widely used as a marker for autophagy. Our data severely question the specificity of this probe. The intensity of the MDC staining was increased and it colocalized with lysotracker-red even in TNF-treated MCF-7 cells where no autophagy could be detected by DsRed1-LC3-b staining or by EM. Furthermore, MDC failed to stain a large proportion of DsRed1-LC3-b-positive vacuoles in EB1089-and tamoxifen-treated autophagic cells. Thus, MDC appears to stain the acidic vacuoles (lysosomes and autolysosomes) of the cells rather than autophagosomes, and previous data reporting autophagy based on MDC uptake should be carefully re-evaluated. In addition to demonstration of autophagic vesicles by EM, changes in the intracellular localization of LC3-b appear as a reliable method to detect autophagy. The characterization of the molecular basis of autophagy will hopefully provide even more reliable biochemical methods in the near future.
Contrary to most reported autophagy models, where autophagy-mediated antiproliferative effects are mainly due to the cell cycle arrest, 16, 26, 40 EB1089-induced autophagy was associated with apoptosis-like cell death characterized by chromatin condensation and DNA fragmentation. Nuclear apoptosis did not only occur in the same cells that showed autophagic morphology but in fact depended on autophagic activity since 3-MA effectively inhibited and overexpression of Beclin 1 enhanced both DNA fragmentation and chromatin condensation. Thus, instead of serving as an adaptive response to maintain continual cell survival under stress conditions, EB1089-induced autophagy appears causal to the cell death. Whether this difference in outcome of autophagy induction is due to different signaling pathways involved or the severity of the response is still unknown.
The discovery of an EB1089-induced autophagic cell death pathway suggests that this compound could be useful in the treatment of cancers mutated in the signaling pathways leading to apoptosis. Moreover, a combination therapy using drugs inducing PCD through different signaling pathways would make it harder for cancer cells to escape death and develop drug resistance. Accordingly, combinations of the active form of vitamin D or its analogues with other cytotoxic agents such as TNF, Taxol, doxorubicin and radiation show synergistic effects. 30, 43, 44 Finding of the optimal therapy combinations will, however, require a more detailed understanding of the EB1089-induced signaling pathways leading to autophagy and PCD. Furthermore, our surprising data showing that tumor cell growth depends on Beclin 1 opens the possibility that inhibitors of autophagy or specific inhibitors of Beclin 1 may prove effective in the treatment of tumors that have lost one allele of Beclin 1 and/or have defects in other autophagy stimulating tumor suppressor genes. In addition to inhibiting tumor cell growth, such treatments may sensitize cells to classic apoptosis pathway.
Materials and Methods
Cell culture and treatments
The MCF-7S1 cell line is a subclone of the human ductal breast carcinoma cell line MCF-7 selected for high TNF sensitivity, 45 and HeLa cell line originates from a human cervix carcinoma (kindly provided by Jiri Bartek, Danish Cancer Society, Copenhagen, Denmark). The cells were cultured in RPMI 1640 with Glutamax (Life Technologies, Lts., Paisley, UK) supplemented with 6% heat-inactivated fetal calf serum (FCS; Biological Industries, Kib. Beit Haemek, Israel), 100 U/ml penicillin and 100 mg/ml streptomycin. The medium of the stably transfected cells contained also 400 mg/ml Geneticin sulfate (G-418; Invitrogen, Carlsbad, CA, USA). The cells were maintained in a humidified atmosphere at 371C, 5% CO 2 , 21% O 2 , 74% N 2 , and regularly tested and found negative for mycoplasma infection.
EB1089 
Cloning and transfections
Cells were transfected by electroporation (960 mF, 330 V) essentially as described previously, 45 
Measurement of cell viability and death
The viability of cells was analyzed by the MTT reduction assay as described previously. 29 The DNA fragmentation (cytosolic histone-bound DNA) was determined using the Cell Death Detection ELISA plus kit (Roche, Mannheim, Germany) and a microtiter plate reader (VERSA max , Molecular Devices LTd, Crawley, UK) according to the manufacture's instructions. The results were normalized to the cell number in cultures treated in parallel, and displayed as arbitrary units. Phase contrast pictures were taken with an inverted Olympus IX-70 microscope connected to an Olympus C-5050 digital camera using Â 20 objective with numerical aperture 1.1.70.5. Image processing was performed with Adobe Photoshop 7.0. Membrane integrity was analyzed by staining cells with 1-2 mM SYTOX Green (S-7020, Molecular Probes) for 10 min, washed in PBS supplemented with 5% FCS and analysed by the FL1-H channel of flow cytometry (Becton Dickinson, San Jose, CA, USA).
Visualization and analyses of intracellular vacuoles
The acidic compartment of cells was analyzed by labeling the cells with 50 nM lysotracker-red (Molecular Probes, Eugene, OR, USA) for 10-15 min and applying Zeiss Axiovert 100 M Confocal Laser Scanning Microscope equipped with LSM510 system using Â 40 Plan-neofluar objective with numerical aperture 1.3.
MDC (Sigma-Aldrich) was applied to the cells at 50 mM for 30-45 min followed by 10 min incubation with 40 mM NH 4 Cl in order to reduce the lysosomal staining and one wash with phosphate-buffered saline (PBS) plus 10% FCS. NH 4 Cl treatment was omitted when costaining with lysotracker-red. Pictures were taken on an inverted fluorescence microscope (Olympus IX-70) with Olympus C-5050 digital camera. The intracellular MDC-fluorescence (excitation 355 nm, emission 460, cutoff 550, well-scan) was quantified by a Spectramax Gemini fluorometer (Molecular Devices, Sunnyvale, CA, USA). The MDC fluorescence intensity was correlated to cell density as measured by MTT reduction assay performed in parallel treated samples. The results are expressed as fluorescence/cell relative to untreated control cells.
DsRed1-LC3-b translocation
Exponentially growing cells were transfected with pDsRed1-LC3-b together with pH2B-eGFP-N1 (4 : 1) by electroporation and seeded 1 day after the transfection on glass chamber slides (#155379, Nalge Nunc International, Roskilde, Denmark). After indicated treatments, the percentage of green cells (a minimum of 100 cells/sample) with red vacuoles (DsRed1-LC3-b translocated from cytosol to autophagic vacuoles) was counted applying Zeiss Axiovert 100 M Confocal Laser Scanning Microscope.
Measurement of protein degradation
Cells were labeled for 24 h with 0.2 mCi/ml 14 C-Valine (Amersham Biosciences) in culture medium, washed three times with PBS and incubated for 1 h in culture medium before adding the indicated stimuli in fresh medium. The media and stimuli were replaced every 24 h. At the time of harvesting, the culture medium was collected and the cells were trypsinized. Cellular proteins were precipitated with 10% trichloroacetic acid at 41C for 10 min and centrifuged at 1000 g for 20 min. The radioactivity in the culture media and the acid-insoluble pellet were determined in a scintillation counter (Wallac, Turku, Finland). The rate of protein degradation was calculated as the level of radioactivity in the culture medium divided by the total radioactivity and is expressed as percent increase upon indicated treatments.
Cysteine Cathepsin activity measurements
After removing the medium, 200 ml extraction buffer (250 mM sucrose, 20 mM HEPES, 10 mM KCl, 1.5 mM MgCl 2 1 mM EDTA, 1 mM EGTA, 1 mM pefabloc SC, pH 7.5) containing 20 mg/ml (cytoplasmic fraction) or 200 mg/m (total cellular fraction) digitonin was added and plates were kept on ice with a gentle shaking for 12 min. The enzyme activity of the samples was determined as described previously employing z-FR-amino-trifluoromethylcoumarin (Enzyme System Products) as substrate for cysteine cathepsins and Spectramax Gemini fluorometer (Molecular Devices, Sunnyvale, CA, USA) for the measurement of Vmax of the liberation of the fluorochrome. 6 All protease activities were normalized to the lactate dehydrogenase activity analyzed by cytotoxicity detection kit (Roche) of the same sample.
Immunoblot analysis
Immunodetection was performed using mouse monoclonal antibodies against Beclin 1 (clone 20; BD Transduction Laboratories; at 1 : 200), FLAG (clone M2; Sigma-Aldrich; at 1 : 100), heat-shock cognate 70 protein (Hsc70; clone N69 kindly provided by Boris Margulis, Russian Academy of Sciences, St. Petersburg, Russia; at 1 : 4000) and GAPDH (Biogenesis, Poole, UK; at 1 : 5000) as primary antibodies, appropriate peroxidase-conjugated secondary antibodies from DAKO A/S and ECL Western blotting reagents from Amersham Pharmacia. The IMAGEJ densitometry software was used to quantify the protein levels.
Transmission and cryo immuno EM
Subconfluent cells fixed in situ for 10 min in 50% Karnovsky fixative were collected by scraping with a rubber policeman, transferred to a centrifugation tube and centrifuged at 1500 g for 5 min. The pellet was washed and stored in 70% Karnovsky fixative at 41C until embedding. After washing in 0.1 M cacodylate buffer, the pellet was embedded in 2% agar, cut into smaller cubes, postfixed in osmium, dehydrated and embedded in Epon according to standard procedures. Ultrathin sections cut on an RMC, MT-7 ultramicrotome were collected on copper grids and stained with 4% uranyl-acetate and Reynolds lead-citrate for ultrastructural examination in a JEOL 1210 electron microscope.
For cryo immuno-EM cells were fixed for 30 min in 4% paraformaldehyde in 0.1 M phosphate buffer (PB) and washed in 0.1 M PB. The pellet was embedded in 15% gelatine (Merck art 4078) in 0.1 M PB for 20 min at 371C, centrifuged at 6000 r.p.m. for 5 min (Sigma 202 MC centrifuge), hardened for 20 min at 41C, cut into 1 mm 3 cubes that were cryo-protected by soaking in 2.3 M PB-buffered sucrose containing 1% paraformaldehyde at 41C for 18 h and frozen on silver stubs in liquid nitrogen. Ultrathin cryosections were cut on a Leica Ultracut UCT/EM FCS cryo ultramicrotome and collected on 200 mesh Formvar-coated nickel grids. A two-or three-layer indirect immunostaining was used as previously described. 46 The primary antibodies used included monoclonal mouse antibodies against cathepsin D (M 7243, Dako A/S, Glostrup, Denmark; at 1.76 mg/l), serca-2 ATPase (#564702, Calbiochem, La Jolla, CA, USA; at 1 : 300), cytochrome c (#556432, BD PharMingen, San Diego, CA USA; at 2.5 mg/l), Hsp60 (SPA-806, StressGen, Victoria, B.C., Canada; at 5.0 mg/l) and polyclonal rabbit antiserum against cathepsin D (A 0561, Dako A/S; at 1 : 300). The secondary antibodies in two-and three-layer indirect immunostainings were F(ab) 2 goat anti-rabbit IgG Ultra-Small (100166, AURION, Wageningen, The Netherlands) and biotinylated rabbit antimouse F(ab) 2 IgG (E0413, Dako A/S; at 1 : 400), respectively, and the tertiary antibody was goat anti-biotin Ultra-Small (100088, AURION). Mouse IgG1 (X 0931, Dako A/S; 2.5-or 5 mg/ml) served as a control.
The sections were silver enhanced using AURION R-GENT silver enhancer (500033, AURION). For contrast and protection against airdrying artefacts, sections were incubated in 2% methyl cellulose containing 0.4% uranyl acetate before viewing in a JEOL 1210 electron microscope.
Measurement of DNA synthesis
Cell proliferation was measured by labeling with 5-bromo-2 0 -deoxy-Uridine (BrdU) incorporation. Cells growing on coverslips were pulsed with 100 mM BrdU (Sigma-Aldrich) for 20-25 min, followed by three washes in cold PBS, fixation in 3.7% formaldehyde (Sigma-Aldrich) for 20 min and permeabilization in 0.2% Triton-X-100 for 4 min. After six washes in PBS, the slides were treated with 10 U/ml DNaseI (Boehringer Mannheim, Mannheim, Germany) for 30 min, washed, incubated for 1 h with 1 : 300 anti-BrdU antibody (#RPN202, Amersham, Little Chalfont, UK) in PBS containing 10% FCS, washed and incubated with Alexat 488 goat-antimouse IgG (Molecular Probes) diluted 1 : 500 in PBS containing 10% FCS for 1 h. After six washes, the cells were mounted on glass slides and the percentage of BrdU-positive cells was counted applying Zeiss Axiovert 100 M Confocal Laser Scanning Microscope.
Statistical analysis
Independent experiments were pooled when the coefficient of variance could be assumed identical. Statistical significance was evaluated using one or two sample t-tests (n ¼ number of independent experiments).
